Chinese VCs increasingly invest in US biotechs

Chinese venture capitals keep heavily investing  in the US biotech industry despite the ongoing commercial war opposing China and US. In the first 6 months of the year, indeed, the China-based VCs have invested $5.1bn, which fairly exceeds the $4bn invested during all 2017 (vs $0.3bn in 2016). This shows that the biotech industry has become a key sector for the Chinese government, which indeed has placed it in a group of 10 sectors included in the latest five-year plan, Pitchbook has reported. Chinese biotech companies are granted significant funding–suffice it to say that they received $11bn in 2017.

(Source: PitchBook)